InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,625.80
(
0.16%
)
US TECH 100
19,070.40
(
0.00%
)
Dow Jones
41,250.50
(
0.02%
)
Brent Oil
78.69
(
-0.38%
)
Bitcoin
59,157.20
(
-0.57%
)
Post# of 23619
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ehihub

Send PM Follow Ignore
Followers 29
Posts 1568
Boards Moderated 0
Alias Born 01/29/2011

ehihub

Re: 02opida post# 8175

Thursday, 04/11/2019 3:47:34 PM

Thursday, April 11, 2019 3:47:34 PM

Post# of 23619
Buyout/ Continue operating if the Brand name sticks by Abbott Labs, Johnson & Johnson, Merck, Proctor & Gamble, etc. are what I’m seeing in the future.

LACTOACTIVE is a novel concept that was totally missed in development by big pharma, IMO.

With one patent in hand and worldwide patents applied for VILACTO BIO. has developed the most effective delivery method for (name your cocktail) into the skin and well deeper.

LACTOACTIVE will be a hot target if not already. Remember, Gert stated he increased the authorized shares to AVOID A HOSTILE TAKEOVER.

ALL IMO
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up